Skip to main content

ADAM Molecules

  • Reference work entry
  • First Online:
Encyclopedia of Cancer
  • 357 Accesses

Synonyms

A disintegrin and metalloprotease; Disintegrin metalloproteases; MDC; Metalloprotease disintegrin cysteine-rich

Definition

A disintegrin and metalloprotease (ADAM) molecules share a common domain structure: a propeptide (prodomain), a metalloproteinase domain, a disintegrin domain, a cysteine-rich region, an epidermal growth factor (EGF)-like domain, a transmembrane region, and a cytoplasmatic domain (Fig. 1). Several ADAMs exist in both membrane-bound and secreted isoforms; the functional significance of this, in most cases, is still unclear. A subset of the presently known ADAM molecules shows catalytic activity. To date, at least 40 ADAMs have been identified in a variety of species. A large proportion (13 ADAMs) is exclusively expressed in the male reproductive system, and only a minority can be found throughout all tissues.

ADAM Molecules. Fig. 1
figure 112 figure 112

Domain structure of ADAMs. The ADAMs consist of a propeptide domain, a metalloprotease domain, a disintegrin domain, a...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 2,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7–30

    Article  CAS  PubMed  Google Scholar 

  2. Gschwind A, Hart S, Fischer OM et al (2004) TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells. EMBO J 22:2411–2421

    Article  Google Scholar 

  3. Ringel J, Jesnowski R, Moniaux N et al (2006) Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Cancer Res 66(18):9045–9053

    Article  CAS  PubMed  Google Scholar 

  4. Iba K, Albrechtsen R, Gilpin BJ et al (1999) Cysteine-rich domain of human ADAM 12 (meltrin a) supports tumor cell adhesion. Am J Pathol 54:1489–1501

    Article  Google Scholar 

  5. Karan D, Lin FC, Bryan M et al (2003) Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. Int J Oncol 23:1365–1371

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jörg Ringel .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Ringel, J., Löhr, M. (2011). ADAM Molecules. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16483-5_73

Download citation

Publish with us

Policies and ethics